UPS and FedEx usually compete fiercely for business. Now, the rivals are working closely together to ship the coronavirus vaccine developed by Pfizer and BioNTech, the first of the vaccines to win U.S. government approval.
The two shipping companies said they had put the plans they had been working on for months into action after the Food and Drug Administration gave the vaccine emergency authorization late Friday.
At a news conference on Saturday, Gen. Gustave F. Perna, the chief operating officer of Operation Warp Speed, the federal effort to bring a vaccine to market, said that boxes were being packed at Pfizer’s plant in Kalamazoo, Mich., and would be shipped within 24 hours to UPS and FedEx distribution hubs, where they would be dispersed to 636 locations across the country.
He said 145 sites would receive the vaccine on Monday, 425 on Tuesday and 66 on Wednesday.
“Make no mistake, distribution has begun,” he said.
In a statement on Saturday, UPS said it would transport doses of the vaccine from storage sites in Michigan and Wisconsin to its air cargo hub in Louisville, Ky. From there, the doses will be distributed to hospitals and other medical facilities using its Next Day Air service, arriving the day after leaving the Pfizer facilities.
“This is the moment of truth we’ve been waiting for,” Wes Wheeler, president of the company’s health care division, said in a statement. “The time has arrived to put the plan into action.”
Even before the vaccine was approved, UPS had started shipping out kits with the medical supplies needed to administer it, such as alcohol wipes and syringes, Mr. Wheeler told a Senate subcommittee this week. UPS and FedEx will split distribution of the vaccine throughout the country, he said. After those shipments arrive, all Pfizer dosing sites will receive another shipment from UPS of 40 pounds of extra dry ice to keep the vaccines at a frigid temperature.
“You have two fierce rivals here, and competitors, in FedEx and UPS, who literally are teaming up to get this delivered,” Richard Smith, a FedEx executive, told the Senate’s Subcommittee on Transportation and Safety on Thursday.
Both companies said the shipments would be closely tracked and monitored, and would be given priority over other packages. To ship its vaccine, Pfizer designed specialized containers packed with enough dry ice to keep a minimum of 975 doses cool for up to 10 days. Each comes with a tracking device.
UPS and FedEx said they would also affix their own tracking tags to vaccine shipments. And Mr. Wheeler told senators that each UPS truck carrying the doses will have a device that tracks its location, temperature, light exposure and motion. The company’s trucks will have escorts, too, he said. It is not clear whether he meant the local police or other government officials, or possibly private guards, and the company declined to specify.
The vaccine administration kits were assembled by McKesson, a medical supplier that was asked by federal authorities to act as a centralized distributor of the vaccines and supplies, such as syringes and alcohol wipes. Unlike Pfizer, Moderna, whose vaccine could be approved soon, plans to have McKesson package its vaccines alongside the supplies, Mr. Smith said.
In the case of Pfizer, UPS plans to deliver the kits — from a McKesson site in Kentucky — in advance of the vaccine, allowing it to identify any errors with addresses in its system, Mr. Wheeler said. The kits contain a syringe, a substance used to dilute the vaccines, personal protective equipment, instructions and mixing vials, he said.
Shippers have spent months upgrading cold storage infrastructure for the Pfizer vaccine, which must be stored at minus 94 degrees Fahrenheit. UPS, for example, has been installing ultralow-temperature freezer farms that are able to keep goods as cold as minus 112 degrees Fahrenheit near its air cargo hubs in the United States and Europe. It also plans to produce more than 24,000 pounds of dry ice per day at its hub in Louisville. FedEx has added ultracold freezers throughout its U.S. network, too.
Airlines have also been preparing to transport the vaccines, working with plane manufacturers and the Federal Aviation Administration to safely carry more dry ice than is typically allowed. UPS is also sending the agency a daily file of its flights so it can help prioritize them over others, Mr. Wheeler said. The company, he said, is in daily contact with officials involved in Operation Warp Speed, the federal effort to accelerate vaccine development.
This weekend, 2.9 million doses of the Pfizer and BioNTech vaccine are to begin traveling by plane and guarded truck from facilities in Michigan and Wisconsin to designated locations, mostly hospitals, in all 50 states.
The first injections are expected to be given by Monday to high-risk health care workers, the initial step toward the goal of inoculating enough Americans by spring to finally halt the spread of a virus that has killed nearly 300,000, sickened millions and upended the country’s economy, education system and daily life. There are now more than 16 million virus cases reported in the United States, according to the data by The Times.
The rapid development of the vaccine, and the F.D.A.’s emergency authorization of it on Friday night based on data showing it to be 95 percent effective, has been a triumph of medical science, but much in this complicated next stage could go wrong.
States say they have only a fraction of the funding they need from the federal government for staffing to administer the shot, for tracking who has received both doses of the vaccine — a booster is needed three weeks after the initial injection — and for other crucial pieces of the effort.
But for all the planning that has been done and contingencies that have been put in place in recent months, there is still a good deal of confusion. States are receiving initial allocations according to a federal formula based strictly on their adult population, but many hospitals say they still don’t know exactly how much they will get or when shipments will arrive. Some hospital systems are reeling from the news that their initial allocations will be much smaller than they had hoped.
One reason for the shortfall in initial supply is that federal officials decided to send out fewer than half of the 6.4 million doses they had planned for the first wave.
Although there is some variation among their plans, states are largely planning to follow recommendations from the Centers for Disease Control and Prevention about who gets vaccinated first: health care workers at high risk of exposure to the virus and residents of nursing homes and other long-term-care facilities, a population that has died from the virus at disproportionately high rates.
On Thursday, as an F.D.A. advisory committee debated whether to recommend authorization of the Pfizer vaccine, the first packages of supplies to administer it — vaccination record cards, masks, visors, information sheets and syringes — arrived at UPMC Presbyterian, a hospital in Pittsburgh.
As many as 300,000 coronavirus cases across the United States can be traced to a two-day conference in Boston attended by 175 biotech executives in February, according to a study published Thursday in the journal Science.
The conference, convened by the drug company Biogen, was one of the earliest examples in the pandemic of what epidemiologists call “superspreading events,” where a gathering of people leads to a huge number of infections. But new genetic data made publicly available in recent months by many states has allowed researchers for the first time to estimate the national scope of its astonishing ripple effect.
“It’s a cautionary tale,” said Bronwyn MacInnis, a genomic epidemiologist at the Broad Institute of Harvard and M.I.T. “When we hear these stories of clusters where 20 or 50 or 100 were affected, that does not account for what happens after.”
To track the spread, the researchers took advantage of a kind of genetic fingerprint that they identified in samples of the virus taken from 28 people who had attended the meeting. An earlier version of the paper published online in June suggested that the conference had seeded tens of thousands of cases in the Boston area alone.
By March, the researchers had found, viruses bearing the same signature began to appear in the viral genomes taken from coronavirus patients in several other states. But by November, viruses containing the marker could be found in 29 states, linked to some 70,000 in Florida alone. And because the viral genome data linked to U.S. cases has grown by tenfold since June, the researchers are able to make a reliable national estimate. The conference, the study estimates, is responsible for 1.9 percent of all cases in the United States since the start of the pandemic.
A vast majority of introductions of the virus into a workplace or home or community fizzle, the researchers noted. But the study highlights how a local event with a mobile population can seed a national outbreak. Because the genetic fingerprint identified in the Biogen attendees existed previously in Europe, it was not possible to reliably estimate how many of the transmissions globally came from the Boston event, the researchers said.
Although the Biogen conference occurred at a time when the coronavirus was barely on the radar for most Americans, it might have important implications for the current pandemic moment. The first, eagerly awaited vaccines have been demonstrated to protect from severe Covid-19 symptoms, but it is not known whether they protect people from transmitting the virus.
“We risk having folks going around thinking ‘all is good,’” Dr. MacInnis said. “Our data reminds us what can happen when transmission is unchecked.’’
Los Angeles County could see “catastrophic suffering and death” in the coming weeks, public health officials warn, as the nation’s most populous county reported another record day of new coronavirus cases.
The 13,737 cases reported on Friday bring the county’s total to more than 500,000, as the county and California struggle to contain an explosion. California officials reported 37,124 cases on Friday, the highest one-day total of the pandemic.
“We’re on a very dangerous track to seeing unprecedented and catastrophic suffering and death here in L.A. County if we can’t stop the surge,” Barbara Ferrer, the county’s public health director, said at a news conference on Friday. “These numbers are overwhelming, and the grief that our community continues to experience can’t be comprehended.”
The number of people hospitalized for Covid-19 has sharply risen over the past month. In early November, fewer than 1,000 people were in hospitals for treatment. Today, there are more than 3,600, according to the latest figures from the county.
The steep rise in cases in California mirrors a national spike. Officials reported more than 236,000 new cases on Friday, yet another single-day case record.
During a news conference on Wednesday, Dr. Ferrer fought through tears as she talked about the state’s rising death toll.
“Over 8,000 people who were beloved members of their families are not coming back,” she said. “And their deaths are an incalculable loss to their friends and their families.”
Over the past month, the average number of daily deaths has increased more than 250 percent in Los Angeles County. In the past week, 357 people there have died and at least 71,079 people have contracted the virus.
“We’re in uncharted territory at this point,” Dr. Ferrer said. “We’re seeing daily numbers of cases and hospitalizations that we’ve not experienced and, frankly, did not anticipate.”
The Food and Drug Administration authorized Pfizer’s Covid-19 vaccine for emergency use on Friday, clearing the way for millions of highly vulnerable people to begin receiving the vaccine within days.
The authorization is a historic turning point in a pandemic that has taken more than 290,000 lives in the United States. With the decision, the United States becomes the sixth country — in addition to Britain, Bahrain, Canada, Saudi Arabia and Mexico — to clear the vaccine. Other authorizations, including by the European Union, are expected within weeks.
The F.D.A.’s decision followed an extraordinary sequence of events on Friday morning when the White House chief of staff, Mark Meadows, told the F.D.A. commissioner, Dr. Stephen Hahn, to consider looking for his next job if he didn’t get the emergency approval done on Friday, according to a senior administration official who spoke on condition of anonymity because he was not authorized to discuss the matter. Dr. Hahn then ordered vaccine regulators at the agency to do it by the end of the day.
The authorization set off a complicated coordination effort from Pfizer, private shipping companies, state and local health officials, the military, hospitals and pharmacy chains to get the first week’s batch of about three million doses to health care workers and nursing home residents as quickly as possible, all while keeping the vaccine at ultracold temperatures.
Pfizer has a deal with the U.S. government to supply 100 million doses of the vaccine by next March. Under that agreement, the shots will be free to the public.
Every state, along with six major cities, has submitted to the federal government a list of locations — mostly hospitals — where the Pfizer vaccine is to ship initially. In populous Florida, the first recipients will be five hospitals, in Jacksonville, Miami, Orlando, Tampa and Hollywood. In tiny, rural Vermont, only the University of Vermont Medical Center and a state warehouse will get supplies.
McKesson Corporation, a giant medical supplier, is sending kits of syringes, alcohol pads, face shields and other supplies to the same sites, where they will meet up with the vaccines that Pfizer is shipping in special boxes, packed with dry ice, designed to keep them at minus 94 degrees Fahrenheit.
The Pfizer packaging will include a device that tracks the location of the box, plus a thermal probe that will make sure the deep freeze is maintained throughout the journey from the company’s distribution sites in Michigan and Wisconsin.
The decision is a victory for Pfizer and its German partner BioNTech, which began working on the vaccine 11 months ago. Vaccines typically take years to develop. The companies’ late-stage clinical trial, which enrolled nearly 44,000 people, was found to be 95 percent effective.
The vaccine will be scarce at first. Pfizer had to scale back earlier estimates because of manufacturing setbacks, and has said it will be able to supply up to 25 million doses before the end of the year, and 100 million total vaccines by March.
Federal officials are initially holding back half of the supply so that they can give a booster shot to recipients three weeks after their first vaccination. Even though only about three million people will receive a vaccine in the first week, officials have held firm on their estimate that, between the Pfizer and Moderna vaccines, which each require two shots, they hope to give at least 20 million people their first dose of a vaccine by the end of the year.
An expert panel advising the F.D.A. on Thursday gave its approval of Pfizer’s vaccine for people 16 and older, and the agency was planning to release the formal authorization on Saturday. That timeline was accelerated by half a day after President Trump attacked Dr. Hahn for failing to authorize a vaccine more quickly. But the accelerated announcement was not expected to speed up the delivery of vaccines around the country.
The first shipments of Pfizer-BioNTech and Moderna vaccine will not be enough to inoculate even just the medical workers and nursing home residents at the top of the waiting list. But if federal regulators grant emergency authorization, millions of doses will soon be shipped across the country, a small but tangible step toward ending the pandemic.
With no publicly available national data on how much vaccine will be sent to each state, The Times surveyed all 50 state health departments — plus territorial governments and other agencies that may receive allocations — seeking information on how many doses they expected before the end of the year.
While some states provided detailed information, others would only discuss an initial shipment or refused to provide any information at all. In some cases, state estimates have shifted significantly over the past several days, and some states and agencies indicated that their estimates would continue to change as new information emerges.
Out of deference to states and other jurisdictions receiving vaccine doses, a senior administration official said, the Department of Health and Human Services is not publicly releasing planning numbers but expects to provide more information in the days ahead.
With coronavirus cases surging, Gov. Andrew M. Cuomo of New York has shifted his strategy sharply away from tackling local clusters and toward protecting the state’s health system in a bid to avoid a return to the worst days of spring, when hospitals were stretched to the limit.
The virus statistic that had transfixed New Yorkers — the rate of tests that come back positive — is no longer the primary driver of state action, as it was when Mr. Cuomo sought to quash viral outbreaks in designated areas. That effort did not stem a rising tide of infections statewide, and the focus now is on hospital capacity.
Far from hastening a broad new round of business closings, the governor’s shift is likely to delay by weeks a potential return of the most stringent restrictions from earlier in the year. A rise in the number of hospitalizations follows an increase in positive cases, and the state has anticipated several steps hospitals can take to expand capacity before a shutdown is needed.
Still, there was one area where Mr. Cuomo was taking no chances. On Friday, he ordered a halt to indoor dining in New York City starting on Monday, saying that the ban was necessary to curb the surging outbreak. But the move prompted a backlash from the struggling restaurant industry, one of the city’s economic engines, with owners saying the governor had not proved that restaurants were a significant factor in spreading the virus.
After months of low positive test rates, New York is now in the same position as other states amid a worsening national outbreak: watching with increased concern as hospital beds fill.
More than 5,300 people were hospitalized across New York as of Thursday, a level not seen since May. The per capita rate of new cases in New York is better than it is in most states, but worse than in others, including Texas and Florida, although testing levels vary.
“If you extrapolate out at this rate of growth, you could be looking at the shutdown of New York City within a month,” Mr. Cuomo said in an interview on Friday.
global roundup
Brittanya Karma posted her bucket list on Instagram last year.
Featured in a magazine? Check. Appear on German TV? Check. Appear on Vietnamese TV? Check. Acquire one million views on Facebook? Check.
The number of check marks on the list is testimony to the fullness of her short life. Ms. Karma, a Vietnamese-German rapper and reality television star, died on Nov. 29 in Hamburg, where she was born and where she lived. She was 29. The cause was complications of Covid-19, her agent said.
Ms. Karma was first noticed several years ago when a Vietnamese-language Facebook post in which she gently mocked her mother went viral, garnering more than a million clicks. She quickly acquired a Vietnamese following by describing her life in Germany and speaking out against body shaming. She soon added a YouTube channel and an Instagram account. Two years ago she started a TikTok account with her fiancé, Eugene Osei Henebeng, who goes by the name Manu.
Ms. Karma used her YouTube channel to communicate with her many Vietnamese followers, and her TikTok to speak with her German fans. In the videos she posted on those channels, as well as on Instagram and Facebook, she told stories, joked or — during this year’s lockdowns — danced around the house with Manu.
“Self-confidence is my superpower,” she said in one of her TikTok videos.
In other global developments:
-
Rizieq Shihab, a radical Indonesian cleric who stirred controversy by holding large gatherings and calling for a “moral revolution” after his return from Saudi Arabia last month, surrendered to the police Saturday on charges of violating coronavirus protocols. Mr. Rizieq, 55, returned to a hero’s welcome from his self-imposed exile, but immediately ran afoul of restrictions on the size of gatherings by inviting 10,000 people to his daughter’s wedding. He also avoided authorities’ attempts to have him undergo a coronavirus swab test. Six of his bodyguards were killed by the police, in what authorities said was self-defense. In surrendering, he said he would cooperate with the police investigation.
Business - Latest - Google News
December 13, 2020 at 12:29AM
https://ift.tt/2W6r3wX
Covid-19 Live Updates: Plans to Ship Vaccine Are Underway - The New York Times
Business - Latest - Google News
https://ift.tt/2Rx7A4Y
Bagikan Berita Ini
Related Posts :
U.S. Buys 200 Million Covid-19 Vaccines From Pfizer and BioNTech at About $24 a Shot - The Wall Street Journal
GM recalls some electric Chevy Bolt vehicles - CBS Evening News- Dow Jones Futures: Market Rally At Highs With Apple Earnings Due; Hold or Sell Tesla Stock? - Investor's Business Daily
- Dutch Teen Who Went to Space With Jeff Bezos Told Him He’s Never Bought Anything on Amazon - Gizmodo
- Jack Dorsey to Twitter Shareholders: We Must 'Invest Aggressively' in Bitcoin - Bitcoin Magazine
0 Response to "Covid-19 Live Updates: Plans to Ship Vaccine Are Underway - The New York Times"
Post a Comment